These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 5083161)

  • 21. The place of subtotal parathyroidectomy in the management of patients with chronic renal failure.
    Katz AI; Hampers CL; Wilson RE; Bernstein DS; Wachman A; Merrill JP
    Trans Am Soc Artif Intern Organs; 1968; 14():376-84. PubMed ID: 5701560
    [No Abstract]   [Full Text] [Related]  

  • 22. Osteodystrophy developing spontaneously in the course of chronic renal failure.
    Stanbury SW; Lumb GA; Mawer EB
    Arch Intern Med; 1969 Sep; 124(3):274-81. PubMed ID: 5806041
    [No Abstract]   [Full Text] [Related]  

  • 23. Skeletal abnormalities in chronic renal insufficiency before and during maintenance hemodialysis.
    Ritz E; Krempien B; Mehls O; Malluche H
    Kidney Int; 1973 Aug; 4(2):116-27. PubMed ID: 4790866
    [No Abstract]   [Full Text] [Related]  

  • 24. Parathyroid suppressibility in renal osteodystrophy.
    Moorhead JF; Varghese Z; Tatler GL; Baillod RA; Ku G; Sweatman AJ; Wills MR
    Proc Eur Dial Transplant Assoc; 1975; 11():465-72. PubMed ID: 1197271
    [No Abstract]   [Full Text] [Related]  

  • 25. [Letter: Is it necessary to wait for the time of parathyroidectomy to treat the hyperparathyroidism of patients with chronic renal insufficiency].
    Bernheim J; Faivre JM
    Nouv Presse Med; 1975 Feb; 4(8):591. PubMed ID: 1129122
    [No Abstract]   [Full Text] [Related]  

  • 26. Indications for parathyroidectomy in patients with chronic renal failure.
    Finch T; Jacobs JK
    Am Surg; 1974 Jan; 40(1):40-4. PubMed ID: 4808621
    [No Abstract]   [Full Text] [Related]  

  • 27. Plasma hydroxyproline in renal osteodystrophy.
    Varghese Z; Moorhead JF; Tatler GL; Baillod RA; Wills MR
    Proc Eur Dial Transplant Assoc; 1973; 10(0):187-96. PubMed ID: 4802560
    [No Abstract]   [Full Text] [Related]  

  • 28. Calcium and phosphate metabolism in chronic renal failure, with particular reference to the effect of 1 alpha-hydroxyvitamin D3.
    Madsen S
    Acta Med Scand Suppl; 1980; 638():3-120. PubMed ID: 6929650
    [No Abstract]   [Full Text] [Related]  

  • 29. 1,25(OH)2D3 and 25-OHD3 in the treatment of renal osteodystrophy: comparison of combined versus 1,25(OH)2D3 administration alone.
    Coen G; Taccone Gallucci M; Bonucci E; Ballanti P; Bianchi AR; Bianchini G; Matteucci MC; Mazzaferro S; Picca S; Taggi F; Cinotti GA; Casciani CU
    Miner Electrolyte Metab; 1983; 9(1):19-27. PubMed ID: 6687749
    [No Abstract]   [Full Text] [Related]  

  • 30. Disappearance of vascular calcifications during treatment of renal osteodystrophy. Two patients treated with high doses of vitamin D and aluminum hydroxide.
    Verberckmoes R; Bouillon R; Krempien B
    Ann Intern Med; 1975 Apr; 82(4):529-33. PubMed ID: 1119767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Parathyroidectomy in chronic renal insufficiency (CRI)].
    Mioli V; Pacchiarotti P; Ragaiolo M; Perilli A; Lombardo V; Boggi R; Tarchini R
    Minerva Nefrol; 1976; 23(2):154-9. PubMed ID: 1004794
    [No Abstract]   [Full Text] [Related]  

  • 32. EFFECTS OF PARATHYROIDECTOMY AND KIDNEY TRANSPLANTATION ON RENAL OSTEODYSTROPHY.
    WILSON RE; BERNSTEIN DS; MURRAY JE; MOORE FD
    Am J Surg; 1965 Sep; 110():384-93. PubMed ID: 14337994
    [No Abstract]   [Full Text] [Related]  

  • 33. Renal osteodystrophy during hemodialysis for chronic renal failure.
    Lirenman DS; Price JD; Lauener RW; Miller HS
    Can Med Assoc J; 1968 Oct; 99(13):668-74. PubMed ID: 5685514
    [No Abstract]   [Full Text] [Related]  

  • 34. Indications for parathyroidectomy in advanced renal disease.
    Buck BA; Robertson RD
    Surg Gynecol Obstet; 1971 Aug; 133(2):218-24. PubMed ID: 4935588
    [No Abstract]   [Full Text] [Related]  

  • 35. [Calcium metabolism disorders caused by impaired renal function].
    Jørstad S
    Tidsskr Nor Laegeforen; 1982 Nov; 102(32):1697-700. PubMed ID: 7167940
    [No Abstract]   [Full Text] [Related]  

  • 36. The advantage of measurement of intact PTH in the prediction of clinical response and calcium metabolism after subtotal parathyroidectomy for renal osteodystrophy.
    Barth RH; Cheigh JS; Sullivan JF; Chami J; Suthanthiran M; Stubenbord WT; Stenzel KH; Rubin AL
    Trans Am Soc Artif Intern Organs; 1983; 29():124-8. PubMed ID: 6673220
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Total parathyroidectomy and autotransplantation of parathyroid tissue for renal hyperparathyroidism. A one- to six-year follow-up.
    Rothmund M; Wagner PK
    Ann Surg; 1983 Jan; 197(1):7-16. PubMed ID: 6848057
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of pyrophosphate in renal osteodystrophy.
    David DS; Sakai S; Granda J; Cheigh JS; Riggio RR; Stenzel KH; Rubin AL
    Trans Am Soc Artif Intern Organs; 1973; 19():440-5. PubMed ID: 4352991
    [No Abstract]   [Full Text] [Related]  

  • 39. Histological renal osteodystrophy, and 25 hydroxycholecalciferol and aluminum levels in patients on continuous ambulatory peritoneal dialysis.
    Gokal R; Ramos JM; Ellis HA; Parkinson I; Sweetman V; Dewar J; Ward MK; Kerr DN
    Kidney Int; 1983 Jan; 23(1):15-21. PubMed ID: 6834691
    [No Abstract]   [Full Text] [Related]  

  • 40. [Hyperparathyroidism in chronic renal insufficiency new clinical and surgical aspects (author's transl)].
    Kovarik J; Roka R; Stummvoll HK; Graf H; Niederle P; Woloszczuk W; Wolf A; Pinggera WF; Fritsch A
    Wien Klin Wochenschr; 1981 Oct; 93(20):625-31. PubMed ID: 7324474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.